Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer

A pharmacokinetically guided phase I study of topotecan and etoposide phosphate was conducted in recurrent ovarian cancer. The scheduling of the topoisomerase I and II inhibitors was determined using in vitro activity data. All patients had recurrent disease following prior platinum-containing chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Levitt, N C, Propper, D J, Madhusudan, S, Braybrooke, J P, Echeta, C, te Poele, R, Davies, S L, Flanagan, E, Hickson, I D, Joel, S, Ganesan, T S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361471/
https://www.ncbi.nlm.nih.gov/pubmed/15956976
http://dx.doi.org/10.1038/sj.bjc.6602657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361471/
https://www.ncbi.nlm.nih.gov/pubmed/15956976
http://dx.doi.org/10.1038/sj.bjc.6602657

Ejemplares similares